Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

EMA for Predicting Treatment Outcomes in Patients With SUD

Neuropsychological Assessment in Real Time of the Implicit Cognition in the Prediction of Relapse of Patients With Substance Use Disorder

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This longitudinal repeated measures study will evaluate participants at the beginning of treatment through an assessment of psychological measures and craving. They will be trained to use a mobile platform, which will be available for 12 days. The assessment will be conducted via Ecological Momentary Assessment (EMA), with scheduled daily access and during situations of consumption risk. Each access will include questions on substance use, depression, anxiety, triggering situations, attitude towards drugs, and a cognitive bias test. The platform will alternate between two tests (Drug Stroop Task and WAT-DUD). Participants will follow a treatment program supervised by professionals. The study aims to recruit 130 participants (65 for alcohol, 65 for cocaine) from the Provincial Service for Drug Dependence and Addictions in Huelva (SPDA). Participants, selected via stratified random sampling, must reside in Huelva, sign informed consent, have a compatible mobile device, and be over 18. Anonymity will be ensured through alphanumeric codes. Upon treatment admission, selected patients will be informed of their participation in the study. Interviews, conducted by psychologists, will outline the study objectives and duration. Patients agreeing to participate will sign informed consent and receive an identification code. Baseline assessment data will be integrated into a database for subsequent statistical analysis. The assessment encompasses the collection of four blocks of information: Block 1. Patients medical history initiated during treatment admission. Block 2. Neuropsychological battery developed by the research team for the baseline evaluation. Block 3. Neuropsychological battery developed by the research team for the web platform measured through Ecological Momentary Assessment (EMA). Block 4. Follow-up information at three and six months provided by SPDA professionals through the patients medical history. To ensure compliance with participant follow-up, a mixed monitoring protocol has been developed, which includes phone calls and WhatsApp messages. This protocol is designed according to social exchange theory so that participants perceive the benefits of their participation as outweighing the costs. The statistical analysis involves identifying outliers and trimming distributions. Data will be averaged per test per person, considering different conditions. Repeated measures ANOVA will analyze factors such as gender and substance type to address study objectives, examining interactions and conducting planned contrasts for specific comparisons.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Patients initiating treatment for addiction to cocaine or alcohol as the primary substance. 2. Patients with a diagnosis of Substance Use Disorder of mild, moderate, or severe severity, according to the 5th Edition of the DSM (Diagnostic and Statistical Manual of Mental Disorders). 3. Maintaining residency in the province of Huelva during the study\'s follow-up period. 4. Willingness to participate in the study by providing willing to sign a consent form. 5. Possessing a mobile device that meets the necessary technical requirements for the installation and operation of the application. Who Should NOT Join This Trial: 1. Patients with severe, unstable mental disorders, as assessed by the clinical team at the treatment centers. 2. Patients with physical or mental disorders that hinder the execution of the tests and assessments included in the study. 3. Patients under the age of 18. 4. Patients with opioid consumption. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Patients initiating treatment for addiction to cocaine or alcohol as the primary substance. 2. Patients with a diagnosis of Substance Use Disorder of mild, moderate, or severe severity, according to the 5th Edition of the DSM (Diagnostic and Statistical Manual of Mental Disorders). 3. Maintaining residency in the province of Huelva during the study\'s follow-up period. 4. Willingness to participate in the study by providing informed consent. 5. Possessing a mobile device that meets the necessary technical requirements for the installation and operation of the application. Exclusion Criteria: 1. Patients with severe, unstable mental disorders, as assessed by the clinical team at the treatment centers. 2. Patients with physical or mental disorders that hinder the execution of the tests and assessments included in the study. 3. Patients under the age of 18. 4. Patients with opioid consumption.

Locations (1)

University of Huelva
Huelva, Spain